Cargando…
Interleukin-4 Receptor Alpha: From Innate to Adaptive Immunity in Murine Models of Cutaneous Leishmaniasis
The interleukin (IL)-4 receptor alpha (IL-4Rα), ubiquitously expressed on both innate and adaptive immune cells, controls the signaling of archetypal type 2 immune regulators; IL-4 and IL-13, which elicit their signaling action by the type 1 IL-4Rα/gamma common and/or the type 2 IL-4Rα/IL-13Rα compl...
Autores principales: | Hurdayal, Ramona, Brombacher, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686050/ https://www.ncbi.nlm.nih.gov/pubmed/29176972 http://dx.doi.org/10.3389/fimmu.2017.01354 |
Ejemplares similares
-
Deletion of Interleukin-4 Receptor Alpha-Responsive Keratinocytes in BALB/c Mice Does Not Alter Susceptibility to Cutaneous Leishmaniasis
por: Govender, Melissa, et al.
Publicado: (2018) -
IL-4 Mediated Resistance of BALB/c Mice to Visceral Leishmaniasis Is Independent of IL-4Rα Signaling via T Cells
por: McFarlane, Emma, et al.
Publicado: (2019) -
Topical Simvastatin as Host-Directed Therapy against Severity of Cutaneous Leishmaniasis in Mice
por: Parihar, Suraj P., et al.
Publicado: (2016) -
Can We Harness Immune Responses to Improve Drug Treatment in Leishmaniasis?
por: Aruleba, Raphael Taiwo, et al.
Publicado: (2020) -
Inflammatory Dendritic Cells, Regulated by IL-4 Receptor Alpha Signaling, Control Replication, and Dissemination of Leishmania major in Mice
por: Hurdayal, Ramona, et al.
Publicado: (2020)